ImmunoGen CEO Confident After Strong Q1
Shares of biotech player ImmunoGen had a tremendous first quarter, CEO Daniel Junius, gives Gregg Greenberg his outlook for the rest of the year.
Disclosure: TheStreet's editorial policy prohibits staff editors and reporters from holding positions in any individual stocks.
